Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (141-150 of 267) with videos related to

Pageof 27
Sort By:
British Journal of Haematology|July 8, 2024
A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapyAlina Sadaf, Min Dong, Amanda Pfeiffer, et al.
The Journal of Pediatrics|October 20, 2015
A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of AngolaPatrick T McGann, Scott D Grosse, Brigida Santos, et al.
Pharmacoeconomics|July 18, 2023
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing RegimensDavid Teigen, Robert O Opoka, Phillip Kasirye, et al.
American Journal of Hematology|April 23, 2013
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypesVivien A Sheehan, Zhaoyu Luo, Jonathan M Flanagan, et al.
Mutation Research|March 17, 2010
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemiaJonathan M Flanagan, Thad A Howard, Nicole Mortier, et al.
Pediatric Blood & Cancer|July 27, 2010
Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionJane S Hankins, Mary Beth McCarville, Claudia M Hillenbrand, et al.
The Journal of Clinical Investigation|December 14, 2011
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technologyMichelle Tsai, Ashley Kita, Joseph Leach, et al.
Pediatric Blood & Cancer|May 29, 2019
Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemiaAubri S Carman, Casey Sautter, Juliana N Anyanwu, et al.
Wellcome Open Research|October 9, 2023
Case Report: β-thalassemia major on the East African coastAlexander W Macharia, George Mochamah, Johnstone Makale, et al.
British Journal of Haematology|September 9, 2016
Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemiaKerri A Nottage, Russell E Ware, Banu Aygun, et al.
Pageof 27

Showing results (141-150 of 267) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|July 8, 2024
A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapyAlina Sadaf, Min Dong, Amanda Pfeiffer, et al.
The Journal of Pediatrics|October 20, 2015
A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of AngolaPatrick T McGann, Scott D Grosse, Brigida Santos, et al.
Pharmacoeconomics|July 18, 2023
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing RegimensDavid Teigen, Robert O Opoka, Phillip Kasirye, et al.
American Journal of Hematology|April 23, 2013
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypesVivien A Sheehan, Zhaoyu Luo, Jonathan M Flanagan, et al.
Mutation Research|March 17, 2010
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemiaJonathan M Flanagan, Thad A Howard, Nicole Mortier, et al.
Pediatric Blood & Cancer|July 27, 2010
Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionJane S Hankins, Mary Beth McCarville, Claudia M Hillenbrand, et al.
The Journal of Clinical Investigation|December 14, 2011
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technologyMichelle Tsai, Ashley Kita, Joseph Leach, et al.
Pediatric Blood & Cancer|May 29, 2019
Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemiaAubri S Carman, Casey Sautter, Juliana N Anyanwu, et al.
Wellcome Open Research|October 9, 2023
Case Report: β-thalassemia major on the East African coastAlexander W Macharia, George Mochamah, Johnstone Makale, et al.
British Journal of Haematology|September 9, 2016
Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemiaKerri A Nottage, Russell E Ware, Banu Aygun, et al.
Pageof 27